A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study of T-817MA in Post-stroke Patients Undergoing Rehabilitation for Upper Limb Hemiplegia
Latest Information Update: 04 Aug 2022
At a glance
- Drugs Edonerpic (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors FUJIFILM Toyama Chemical
Most Recent Events
- 21 Jul 2021 Status changed from recruiting to active, no longer recruiting.
- 13 Aug 2019 New trial record